| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/14/2002 | US6387663 Fusion protein of collagen binding domain and angiogenesis modulating domain; treatment of cardiovascular disorders; antiischemic agents |
| 05/14/2002 | US6387662 Constructing recombinant dna encoding core protein, envelope 1 protein, and envelope 2 protein; expressing dna in eukaryotic host cell and allowing assembly; then isolating non-infectious particle |
| 05/14/2002 | US6387417 Hinokitol, a metal complex or salt |
| 05/14/2002 | US6387396 In gene therapy and in in vitro and in vivo transfection |
| 05/14/2002 | US6387377 Acellular antibordetella vaccine |
| 05/14/2002 | US6387376 Recombinant vaccine containing feline herpes virus type 1 particularly for treating feline infectious peritonitis |
| 05/14/2002 | US6387365 Alpha interferon and ribavirin where the amount of alpha interferon is less than 3 million iu weekly, qod or daily; alpha interferon is interferon alpha2; reduction of side effects |
| 05/14/2002 | US6387352 Phosphate containing solution and calcium containing solution which when combined form a supersaturated calcium phosphate rinse for treating and preventing oral disease of soft tissues and for remineralization of hard tissues |
| 05/14/2002 | CA2354832C Chlorella preparations exhibiting immunomodulating properties |
| 05/14/2002 | CA2260898C Phosphinate based inhibitors of matrix metalloproteases |
| 05/14/2002 | CA2202030C Method for reducing unwanted cellular adhesions |
| 05/14/2002 | CA2118757C Aza cyclohexapeptide compounds |
| 05/10/2002 | WO2002036806A2 Expression vectors able to elicit improved immune response and methods of using same |
| 05/10/2002 | WO2002036792A2 Dna expression vectors |
| 05/10/2002 | WO2002036741A2 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme |
| 05/10/2002 | WO2002036734A2 Aza-and polyaza-naphthalenyl ketones useful as hiv integrase inhibitors |
| 05/10/2002 | WO2002036733A2 Cd36 as a heat shock protein receptor and uses thereof |
| 05/10/2002 | WO2002036627A2 Interferons, uses and compositions related thereto |
| 05/10/2002 | WO2002036625A2 Prokineticin polypeptides, related compositions and methods |
| 05/10/2002 | WO2002036617A2 A recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine |
| 05/10/2002 | WO2002036612A1 Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane-associating elements |
| 05/10/2002 | WO2002036611A2 Immunomodulatory peptides derived from heat shock proteins and uses thereof |
| 05/10/2002 | WO2002036605A2 Estrone-derivatives having cytoprotective activity |
| 05/10/2002 | WO2002036584A1 Cholesterol lowering benzo`b! thiophenes and benzo`d! isothiazoles |
| 05/10/2002 | WO2002036576A1 Phthalazinone derivatives |
| 05/10/2002 | WO2002036547A1 Cyclopropanecarboxylic acid amide compounds and medicinal use thereof |
| 05/10/2002 | WO2002036203A2 Azole containing compositions with enhanced antifungal activity |
| 05/10/2002 | WO2002036202A2 Methods and compositions for the improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes and alpha lipoic acid |
| 05/10/2002 | WO2002036160A2 Method for obtaining antigenic structures enhancing specific cross reactivity |
| 05/10/2002 | WO2002036159A2 Immunoprotective recombinant antigen from anaplasma marginale, vaccine compositions and methods of use |
| 05/10/2002 | WO2002036150A1 Gene-digesting gene and enzyme having vaccine-like effect |
| 05/10/2002 | WO2002036149A2 Methods for obtaining inhibitors of t-cell membrane protein (tirc7) ligand binding and uses thereof |
| 05/10/2002 | WO2002036146A2 Epitope-beta microglobulin polynucleotide for anti-cancer immunotherapy |
| 05/10/2002 | WO2002036110A2 Oral self-emulsifying formulations of pyranone protease inhibitors |
| 05/10/2002 | WO2002036108A2 Use of 20-hete synthesizing enzyme inhibitors as therapy for cerebral vascular diseases |
| 05/10/2002 | WO2002036073A2 Receptor antagonist-lipid conjugates and delivery vehicles containing same |
| 05/10/2002 | WO2002036072A2 Method for short-term and long-term drug dosimetry |
| 05/10/2002 | WO2002036055A1 Biodegradable microbicidal vaginal barrier device |
| 05/10/2002 | WO2002035981A2 Methods and compositions for the treatment of human immunodeficiency virus infection |
| 05/10/2002 | WO2002035942A1 Food grade transglutaminase inhibitor and uses thereof |
| 05/10/2002 | WO2002028868A8 Thiazine derivatives |
| 05/10/2002 | WO2002022600A3 Chemokine receptor binding heterocyclic compounds |
| 05/10/2002 | WO2002020057A3 Flavoring systems for pharmaceutical compositions and methods of making such compositions |
| 05/10/2002 | WO2002016381A3 Composition and method for inhibiting platelet aggregation |
| 05/10/2002 | WO2002014464A3 Plant-derived and synthetic phenolic compounds and plant extracts, effective in the treatment and prevention of chlamydial infections |
| 05/10/2002 | WO2002004492A3 Herpes zinc finger motifs |
| 05/10/2002 | WO2002000885A9 Assembly of wild-type and chimeric influenza virus-like particles (vlps) |
| 05/10/2002 | WO2001097824A3 Use of phyllanthus constituents for treating or preventing infections caused by flaviviridae |
| 05/10/2002 | WO2001090316A3 Human circulating dendritic cell compositions and methods |
| 05/10/2002 | WO2001085993A3 Method for detecting growth hormone variations in humans, the variations and their uses |
| 05/10/2002 | WO2001079469A3 Cloning of corynebacteriaceae histidine ammonia lyase and therapeutic uses |
| 05/10/2002 | WO2001079288A3 Cytokine uses; compositions; methods |
| 05/10/2002 | WO2001076570A3 Use of substances that act as cascade inhibitors of the raf/mek/erk signal cascade, for producing a medicament to treat dna and rna viruses |
| 05/10/2002 | WO2001074329A3 Sustained release beadlets containing stavudine |
| 05/10/2002 | WO2001070706A3 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents |
| 05/10/2002 | WO2001068697A3 Methods and compositions for immunoregulation |
| 05/10/2002 | WO2001068034B1 1, 2, 4-triazoloribonucleoside prodrugs and their administration to treat viral disease conditions |
| 05/10/2002 | WO2001066742A3 G-protein coupled receptors |
| 05/10/2002 | WO2001066594A3 Human protein kinases and protein kinase-like enzymes |
| 05/10/2002 | WO2001064879A3 G-proteins coupled receptor related polypeptides |
| 05/10/2002 | WO2001047963A3 Inhibitors of complement activation, their preparation and use |
| 05/10/2002 | WO2001047962A3 Attenuated microorganisms for the treatment of infection |
| 05/10/2002 | WO2001047955A3 Improvements in or relating to immune responses to hiv |
| 05/10/2002 | WO2001041780A3 Use of an immunosuppressant for increasing an antifugal activity of a lipopeptide |
| 05/10/2002 | WO2001036487A3 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/10/2002 | WO2001034641A8 Antimicrobial activity of the first cationic cluster of human lactoferrin |
| 05/10/2002 | WO2001032709A3 Polypeptides with non-natural primary signalling motifs |
| 05/10/2002 | WO2001032650A3 Alkaline salts of n-(6-alkyl-2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinesulfone)-n'-isonicotinoylhydrazide, possess for their preparation, and pharmaceutical composition based on these salts |
| 05/10/2002 | WO2001027146A9 Chemokine receptor |
| 05/10/2002 | WO2001023386A3 Benzodiazepin derivatives, the production and use thereof |
| 05/10/2002 | WO2001021203A9 Use of an outer membrane protein a of an enterobacterium associated with a rsv immunogenic peptide for preparing vaccines for intranasal administration |
| 05/10/2002 | WO2001003681A3 Use of flavones, coumarins and related compounds to treat infections |
| 05/10/2002 | WO2001000877A3 Method of isolation of regulated virulence determinants from bacterial pathogens |
| 05/10/2002 | WO2000073507A3 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders |
| 05/10/2002 | WO2000067761A8 Compositions and methods for identifying antigens which elicit an immune response |
| 05/10/2002 | WO2000058339A3 50 human secreted proteins |
| 05/10/2002 | WO2000054802A3 Method of expressing antigens on the surface of antigen presenting cells by photochemical internalization |
| 05/10/2002 | WO2000053603A9 2-hydroxy methylcyclopro pylidenemethyl purines and -pyrimidines as antiviral agents |
| 05/10/2002 | CA2463623A1 Epitope-beta microglobulin polynucleotide for anti-cancer immunotherapy |
| 05/10/2002 | CA2427952A1 Dna expression vectors |
| 05/10/2002 | CA2427850A1 Interferons, uses and compositions related thereto |
| 05/10/2002 | CA2427800A1 Prokineticin polypeptides, related compositions and methods |
| 05/10/2002 | CA2427572A1 Immunomodulatory peptides derived from heat shock proteins and uses thereof |
| 05/10/2002 | CA2427557A1 Use of 20-hete synthesizing enzyme inhibitors as therapy for cerebral vascular diseases |
| 05/10/2002 | CA2427539A1 Method for obtaining antigenic structures enhancing specific cross reactivity |
| 05/10/2002 | CA2427518A1 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme |
| 05/10/2002 | CA2427257A1 Expression vectors able to elicit improved immune response and methods of using same |
| 05/10/2002 | CA2427194A1 Method for short-term and long-term drug dosimetry |
| 05/10/2002 | CA2427193A1 Food grade transglutaminase inhibitor and uses thereof |
| 05/10/2002 | CA2426012A1 Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane-associating elements |
| 05/10/2002 | CA2425583A1 Methods for obtaining inhibitors of tirc7 ligand binding and uses thereof |
| 05/10/2002 | CA2425067A1 Aza-and polyaza-naphthalenyl ketones useful as hiv integrase inhibitors |
| 05/10/2002 | CA2424932A1 Cd36 as a heat shock protein receptor and uses thereof |
| 05/10/2002 | CA2395324A1 Expression potentiator for protein synthesis regulatory gene |
| 05/09/2002 | WO2002036153A1 Expression potentiator for protein synthesis regulatory gene |
| 05/09/2002 | US20020055636 Pyrroloquinolones as antiviral agents |
| 05/09/2002 | US20020055632 Such as (3R,5S)-1-pyrimidin-2-yl-5-(2,4,5-trifluoro-benzyloxymethyl)-pyrrolidine-3 -thiol trifluoro-acetate useful as inhibitors of metalloproteases for treating diseases associated with vasoconstriction |
| 05/09/2002 | US20020055615 Functional role of adrenomedullin (AM) and the gene-related product (PAMP) in human pathology and physiology |
| 05/09/2002 | US20020055518 Polyoxyethylated hydroxyesters of rapamycin useful in inducing immunosuppression and in the treatment of transplantation rejection, autoimmune diseases, solid tumors, fungal infections, and vascular disease. |
| 05/09/2002 | US20020055517 Methods for delaying recurrence of herpes virus symptoms |